CenterBook Partners LP Invests $1.18 Million in U.S. Physical Therapy, Inc. (NYSE:USPH)

CenterBook Partners LP bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,268 shares of the company's stock, valued at approximately $1,177,000. CenterBook Partners LP owned about 0.11% of U.S. Physical Therapy at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of USPH. Commerce Bank increased its stake in U.S. Physical Therapy by 15.4% in the first quarter. Commerce Bank now owns 3,814 shares of the company's stock valued at $276,000 after purchasing an additional 509 shares in the last quarter. Cetera Investment Advisers increased its stake in U.S. Physical Therapy by 10.4% in the first quarter. Cetera Investment Advisers now owns 8,232 shares of the company's stock valued at $596,000 after purchasing an additional 774 shares in the last quarter. GW&K Investment Management LLC increased its stake in U.S. Physical Therapy by 8.9% in the first quarter. GW&K Investment Management LLC now owns 344,390 shares of the company's stock valued at $24,920,000 after purchasing an additional 28,203 shares in the last quarter. MQS Management LLC bought a new stake in U.S. Physical Therapy in the first quarter valued at approximately $377,000. Finally, Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 5.6% in the first quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company's stock valued at $22,901,000 after purchasing an additional 16,698 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock traded down $0.91 during midday trading on Friday, hitting $74.04. 130,598 shares of the company traded hands, compared to its average volume of 125,318. The stock has a market cap of $1.12 billion, a price-to-earnings ratio of 33.96, a PEG ratio of 3.59 and a beta of 1.44. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The firm's fifty day moving average price is $76.84 and its 200-day moving average price is $78.39. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. During the same period in the previous year, the firm posted $0.51 EPS. The firm's revenue was up 18.0% on a year-over-year basis. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.43%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

Insider Activity

In other news, Director Nancy Ham sold 400 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the transaction, the director owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several brokerages recently commented on USPH. JMP Securities restated a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Finally, Barrington Research reissued an "outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.